# Change Impact Analysis 0.4.2

## Scope

This record summarizes the 0.4.2 impact relative to 0.4.1 and identifies the remaining work required for a 0.4.3 evidence-focused release.

## Summary

0.4.2 moved the runtime controller 10k lane from an unbounded readiness risk to a bounded, auditable software evidence path. It did not convert simulated evidence into physical HIL evidence, named independent sign-off, or clinical-test authorization readiness.

## Implemented impact

- Runtime controller 10k validation now supports a bounded default execution mode for routine CI/readiness runs.
- The 10k lane records target cycles, executed cycles, elapsed timing, projection timing, timeout state, and pass/fail status.
- Clinical-readiness reporting recognizes generated HIL software evidence artifacts instead of treating the HIL lane as pure scaffold.
- QMS document, traceability, placeholder, evidence-artifact, and disabled-test impact checks remain operational.

## Configuration-management finding

0.4.2 still carried several HIL artifacts stamped as 0.4.1. That is acceptable as historical evidence, but it is not acceptable as the only evidence stamp for a 0.4.2+ package. The 0.4.3 work item is to make the HIL generators accept an explicit `--version` argument and emit version-stamped artifacts.

## Residual blockers

- Physical HIL bench records are absent.
- Named independent sign-off is absent.
- HIL coverage must be expanded from partial coverage to 18/18 hazards covered or justified.
- Runtime 10k bounded projection evidence must be separated from full 10k execution evidence.
- Cybersecurity evidence still requires executed scan/test records rather than placeholders or plans alone.

## 0.4.3 action carried forward

Generate versioned HIL artifacts, split bounded/full runtime 10k evidence, and keep ClinicalTestReady blocked unless full 10k execution, physical HIL evidence, signed risk acceptance, cybersecurity evidence, and country-specific package reviews are present.
